Novartis AG (NVS)
131.00
+0.83
(+0.64%)
USD |
NYSE |
Dec 09, 16:00
131.26
+0.26
(+0.20%)
After-Hours: 19:02
Novartis Total Liabilities (Quarterly): 62.54B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Avidity Biosciences, Inc. | 247.94M |
| Monte Rosa Therapeutics, Inc. | 214.00M |
| Tourmaline Bio, Inc. | 10.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.29B |
| Shareholders Equity (Quarterly) | 44.33B |
| Debt to Equity Ratio | 0.7224 |
| Current Ratio | 0.8812 |
| Net Debt Paydown Yield | -0.25% |